Rhythm Pharmaceuticals Inc (RYTM)
41.51
+1.71
(+4.30%)
USD |
NASDAQ |
May 01, 16:00
41.51
0.00 (0.00%)
After-Hours: 20:00
Rhythm Pharmaceuticals Total Assets (Quarterly): 332.74M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 332.74M |
| September 30, 2023 | 354.20M |
| June 30, 2023 | 309.94M |
| March 31, 2023 | 345.68M |
| December 31, 2022 | 382.48M |
| September 30, 2022 | 389.61M |
| June 30, 2022 | 277.68M |
| March 31, 2022 | 284.82M |
| December 31, 2021 | 329.52M |
| September 30, 2021 | 355.82M |
| June 30, 2021 | 388.39M |
| March 31, 2021 | 422.21M |
| December 31, 2020 | 187.07M |
| September 30, 2020 | 215.48M |
| Date | Value |
|---|---|
| June 30, 2020 | 243.48M |
| March 31, 2020 | 273.76M |
| December 31, 2019 | 308.52M |
| September 30, 2019 | 177.53M |
| June 30, 2019 | 210.89M |
| March 31, 2019 | 236.50M |
| December 31, 2018 | 260.21M |
| September 30, 2018 | 277.73M |
| June 30, 2018 | 291.75M |
| March 31, 2018 | 139.44M |
| December 31, 2017 | 151.74M |
| September 30, 2017 | 34.80M |
| June 30, 2017 | 40.88M |
| December 31, 2016 | 12.34M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
177.53M
Minimum
Sep 2019
422.21M
Maximum
Mar 2021
304.73M
Average
309.94M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Pfizer Inc | 226.50B |
| Insmed Inc | 1.330B |
| Altimmune Inc | 210.64M |
| Regeneron Pharmaceuticals Inc | 33.08B |
| Viking Therapeutics Inc | 967.52M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 162.99M |
| Shareholders Equity (Quarterly) | 169.76M |
| Current Ratio | 5.584 |